JPRN-UMIN000005817Recruiting未知
The Effect of Using Candesarsan and Amlodipine for Hypertensive Patients with Dyslipidemia in Japan - EARTH-trial
The Cardiovascular Institute0 sites40 target enrollmentStarted: June 22, 2011Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Sponsor
- Enrollment
- 40
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1.Malignancy 2.Contraindication to take candesartan, amlodipine and pitabastatin. 3.Familial hypercholesterolemia 4.Acute coronary syndrome 5.Already enrollment other clinical trials. 6.Mismatched patients
Investigators
Similar Trials
Unknown
Phase 2
A Dose Selection Trial of CKD-330 in Patients With Essential HypertensionEssential HypertensionNCT02206165Chong Kun Dang Pharmaceutical456
Active, not recruiting
Phase 1
Effet de l’association fixe amlodipine/valsartan sur la Pression artérielle centrale chez des hypertendus essentiels non contrôlés par amlodipine 5mg - Etude EXPLORHypertension artérielle essentielleMedDRA version: 9.1Level: LLTClassification code 10020775Term: Hypertension arterialEUCTR2006-006733-41-FRovartis Pharma S.A.S.532
Completed
Not Applicable
Effect of combination therapy with amlodipine and atorvastatin on blood pressure varaiability, vascular function and renal function in hypertensive patients with chronic kidney diseaseHypertension with chronic kidney disease (CKD stage 1-4)JPRN-UMIN000009045Yokohama city university hospital50
Completed
Phase 3
effects of amlodipine to reduce cardiac iron overloadMajor Thalasemia.Beta thalassemiaD56.1IRCT20190829044642N1Arak University of Medical Sciences30
Active, not recruiting
Not Applicable
A TElmisartan and AMlodipine STudy to Assess the cardiovascular PROTECTive effects as measured by endothelial dysfunction in hypertensive at risk patients beyond blood pressure - TEAMSTA PROTECT I?Male and female, treated and treatment-naive patients with uncontrolled hypertension (defined as 20/10 mmHg above target BP of <140/90 mmHg [<130/80 mmHg for renally impaired and/ or diabetics patients])?Male and female treated patients with controlled hypertension (defined as target BP < 140/90 mmHg [ < 130/80 mmHg for renally impaired and/ or diabetics patients])MedDRA version: 13.1Level: PTClassification code 10020772Term: HypertensionSystem Organ Class: 10047065 - Vascular disordersEUCTR2009-017010-68-DEniversitätsmedizin der Johannes Gutenberg-Universität Mainz